Renal function and requirement for dialysis in chronic nephropathy patients on long-term ramipril: REIN follow-up trial-Reference-Cited by-同舟云学术

Renal function and requirement for dialysis in chronic nephropathy patients on long-term ramipril: REIN follow-up trial

Published:1998-10 Issue:9136 Volume:352 Page:1252-1256
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Ruggenenti Piero,Perna Annalisa,Gherardi Giulia,Gaspari Flavio,Benini Roberto,Remuzzi Giuseppe

Publisher

Elsevier BV

Subject

General Medicine

Reference13 articles.

1. A long-term, randomised clinical trial to evaluate the effects of ramipril on the evolution of renal function in chronic nephropathies;Gruppo Italiano di Studi Epidemiologici in Nefrologia (GISEN);J Nephrol,1991

2. Randomised placebo controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy;The GISEN Group;Lancet,1997

3. Understanding the nature of renal disease progression;Remuzzi;Kidney Int,1997

4. Plasma clearance of nonradioactive iohexol as a measure of glomerular filtration rate in patients with normal ot impaired renal function;Gaspari;J Am Soc Nephrol,1995

5. An analysis of variance test for normality;Shapiro;Biometrika,1965

Cited by 482 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A molecular mechanism for angiotensin II receptor blocker‐mediated slit membrane protection: Angiotensin II increases nephrin endocytosis via AT1‐receptor‐dependent ERK 1/2 activation;The FASEB Journal;2024-08-30

2. GFR measurement in patients with CKD: Performance and feasibility of simplified iohexol plasma clearance techniques;PLOS ONE;2024-07-17

3. Managing Heart Failure in Chronic Kidney Disease: A Review of Current Literature;Current Treatment Options in Cardiovascular Medicine;2024-07-02

4. Renin–angiotensin–aldosterone system blockers effect in chronic kidney disease progression in hypertensive elderly patients without proteinuria: PROERCAN trial;Hipertensión y Riesgo Vascular;2024-04

5. Current perspectives and trends of the research on hypertensive nephropathy: a bibliometric analysis from 2000 to 2023;Renal Failure;2024-02-12